Data Table for Rate/Trend Comparison by State/County

Death Rate/Trend Comparison by State/County, death years through 2011
Colorado versus United States

All Races, Both Sexes
Sorted by Priority Index
Cancer Site
sort cancer ascending
Priority Index1
1=highest
9=lowest

sort index descending
Recent
Trend2

State Death Rate
Compared to
US Rate

Deaths per year
2011

sort death count ascending
Annual
Death
Rate
2011

deaths per 100,000

(95% Confidence Interval)
sort death rate ascending
Rate
Ratio3
State to USsort rate ratio ascending
Recent Average Annual
Percent Change2
in Death Rates

(95% Confidence Interval)
sort AAPC ascending
Recent Trend Period2
Liver & Bile Duct (Females)2rising  similar  873.2 (2.5, 3.9)0.8712242521.3 (0.3, 2.4)2007 - 2011
Liver & Bile Duct (Males)2rising  similar  2208.8 (7.6, 10.1)0.9699224883.3 (2.5, 4.2)2007 - 2011
Melanoma of the Skin (Males)2rising  similar  944.3 (3.4, 5.3)1.0576616841.0 (0.0, 2.0)2007 - 2011
Bladder (Females)6stable  similar  542.0 (1.5, 2.6)0.898681400-0.5 (-1.6, 0.6)2007 - 2011
Brain & ONS (Males)6stable  similar  1285.4 (4.5, 6.5)1.038434766-0.7 (-1.5, 0.1)2007 - 2011
Esophagus (Females)6stable  similar  311.2 (0.8, 1.7)0.764244473-0.1 (-1.5, 1.4)2007 - 2011
Kidney & Renal Pelvis (Females)6stable  similar  642.4 (1.8, 3.0)0.924788370-1.1 (-2.2, 0.1)2007 - 2011
Kidney & Renal Pelvis (Males)6stable  similar  1255.3 (4.4, 6.4)0.937434172-0.6 (-1.3, 0.1)2007 - 2011
Melanoma of the Skin (Females)6stable  similar  602.2 (1.6, 2.8)1.289828707-0.2 (-1.4, 1.1)2007 - 2011
Oral Cavity & Pharynx (Females)6stable  similar  371.4 (1.0, 1.9)1.063190577-1.5 (-3.1, 0.1)2007 - 2011
Pancreas (Females)6stable  similar  2459.2 (8.1, 10.5)0.965084825-0.0 (-0.7, 0.6)2007 - 2011
Uterus (Females)6stable  similar  1053.8 (3.1, 4.6)0.842098252-0.0 (-0.9, 0.8)2007 - 2011
Bladder (Males)7stable  below  1306.4 (5.3, 7.7)0.842434008-0.5 (-1.2, 0.2)2007 - 2011
Esophagus (Males)7stable  below  1325.9 (4.9, 7.1)0.799076488-5.0 (-12.0, 2.5)2007 - 2011
Brain & ONS (Females)8falling  similar  863.1 (2.5, 3.9)0.912487656-1.0 (-1.8, -0.3)2007 - 2011
Breast (Females)8falling  similar  55019.6 (18.0, 21.4)0.911233006-2.2 (-2.6, -1.9)2007 - 2011
Leukemia (Females)8falling  similar  1274.7 (3.9, 5.6)0.902366139-1.0 (-1.6, -0.4)2007 - 2011
Non-Hodgkin Lymphoma (Females)8falling  similar  1124.1 (3.4, 5.0)0.883472873-4.2 (-5.4, -3.1)2007 - 2011
Ovary (Females)8falling  similar  2047.5 (6.5, 8.6)0.994739707-1.7 (-3.4, -0.1)2007 - 2011
Prostate (Males)8falling  similar  41622.5 (20.4, 24.8)1.083997639-3.1 (-3.5, -2.8)2007 - 2011
Stomach (Females)8falling  similar  501.9 (1.4, 2.5)0.815374453-3.6 (-4.7, -2.5)2007 - 2011
Stomach (Males)8falling  similar  833.9 (3.1, 4.9)0.888157964-3.6 (-4.3, -3.0)2007 - 2011
Cervix (Females)9falling  below  381.4 (1.0, 1.9)0.587966056-2.8 (-3.8, -1.8)2007 - 2011
Colon & Rectum (Females)9falling  below  30911.2 (10.0, 12.6)0.877436821-2.3 (-2.7, -1.9)2007 - 2011
Colon & Rectum (Males)9falling  below  32415.0 (13.3, 16.8)0.828743224-4.2 (-5.8, -2.7)2007 - 2011
Leukemia (Males)9falling  below  1687.9 (6.7, 9.3)0.854448784-1.2 (-1.8, -0.7)2007 - 2011
Lung & Bronchus (Females)9falling  below  74528.2 (26.2, 30.3)0.761595238-2.5 (-3.6, -1.4)2007 - 2011
Lung & Bronchus (Males)9falling  below  84538.9 (36.2, 41.7)0.672062177-2.4 (-2.7, -2.2)2007 - 2011
Non-Hodgkin Lymphoma (Males)9falling  below  1386.6 (5.5, 7.9)0.843232458-1.7 (-2.5, -1.0)2007 - 2011
Oral Cavity & Pharynx (Males)9falling  below  632.7 (2.0, 3.5)0.696551436-1.7 (-2.3, -1.1)2007 - 2011
Pancreas (Males)9falling  below  24310.5 (9.2, 12.0)0.842391841-0.5 (-1.1, -0.0)2007 - 2011
Childhood (Ages <15, All Sites) (Females)
*
stable
*
*
*
*
-1.2 (-3.6, 1.3)2007 - 2011
Childhood (Ages <15, All Sites) (Males)
*
falling
*
*
*
*
-3.6 (-6.1, -1.1)2007 - 2011
Childhood (Ages <20, All Sites) (Females)
*
stable
*
*
*
*
-1.0 (-3.1, 1.2)2007 - 2011
Childhood (Ages <20, All Sites) (Males)
*
falling
*
*
*
*
-3.0 (-5.1, -0.8)2007 - 2011
Thyroid (Females)
*
stable
*
*
*
*
-0.3 (-2.5, 2.0)2007 - 2011
Thyroid (Males)
*
rising
*
*
*
*
3.1 (0.2, 6.1)2007 - 2011
Notes:
Created by statecancerprofiles.cancer.gov on 10/31/2014 8:30 pm.
Trend2
     Rising     when 95% confidence interval of average annual percent change is above 0.
     Stable     when 95% confidence interval of average annual percent change includes 0.
     Falling     when 95% confidence interval of average annual percent change is below 0.
Rate Comparison
     Above     when 95% confident the rate is above and Rate Ratio3 > 1.10
     Similar     when unable to conclude above or below with confidence.
     Below     when 95% confident the rate is below and Rate Ratio3 < 0.90

* Data has been suppressed to ensure confidentiality and stability of rate and trend estimates.
** Data are too sparse to provide stable estimates of annual rates needed to calculate trend.
1 Priority indices were created by ordering from rates that are rising and above the comparison rate to rates that are falling and below the comparison rate.
2 Recent trend in death rates is Average Annual Percent Change (AAPC) based on the APCs calculated by Joinpoint Regression Program. Due to data availability issues, the time period used in the calculation of the joinpoint regression model may differ for counties.
3 Rate ratio is the county rate divided by the US rate.

Source: Death data provided by the National Vital Statistics System public use data file. Death rates calculated by the National Cancer Institute using SEER*Stat. Death rates are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). The Healthy People 2020 goals are based on rates adjusted using different methods but the differences should be minimal. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2012 US Population Data File is used with mortality data.

Note: When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate. Suppression is used to avoid misinterpretation when rates are unstable.

State Cancer Registries may provide more current or more local data. Data presented on the State Cancer Profiles Web Site may differ from statistics reported by the State Cancer Registries (for more information).